title: Infliximab: a novel treatment for sight-threatening thyroid associated ophthalmopathy.
abstract: We describe a patient with sight threatening thyroid associated ophthalmopathy (TAO) who was successfully treated with infliximab, an anti-tumour necrosis factor (TNF)-a antibody.
authors.affiliation: Academic Unit of Ophthalmology, the University of Birmingham, UK.
authors.forename: O M
authors.initials: OM
authors.lastname: Durrani
authors.forename: T Q
authors.initials: TQ
authors.lastname: Reuser
authors.forename: P I
authors.initials: PI
authors.lastname: Murray
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005128:Eye Diseases / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006111:Graves Disease / Q000150:complications*; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab